Press release Read more about ABIONYX Pharma: Monthly Statement of Total Voting Rights and Shares Forming the Company’s Share Capital
Press release Read more about Boehringer Ingelheim and OSE Immunotherapeutics advance clinical development of first-in-class SIRP cancer immunology treatment BI 770371
Press release Read more about Monthly information related to total number of voting rights and shares composing the share capital – July 1, 2024
Press release Read more about Half-year report on Worldline SA’s liquidity contract as of June, 30 2024
Press release Read more about Voltalia SA: Half-year statement of the liquidity contract as of June 30, 2024
Press release Read more about Mercialys: Number of Outstanding Shares and Voting Rights as of June 30, 2024